WW vs. NVO
Compare and contrast key facts about WW International, Inc. (WW) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WW or NVO.
Correlation
The correlation between WW and NVO is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
WW vs. NVO - Performance Comparison
Loading data...
Key characteristics
WW:
-0.34
NVO:
-1.13
WW:
0.49
NVO:
-1.63
WW:
1.06
NVO:
0.79
WW:
-0.82
NVO:
-0.79
WW:
-1.51
NVO:
-1.49
WW:
54.67%
NVO:
31.68%
WW:
243.86%
NVO:
42.39%
WW:
-99.87%
NVO:
-71.29%
WW:
-99.64%
NVO:
-54.34%
Fundamentals
WW:
$29.70M
NVO:
$288.72B
WW:
-$4.34
NVO:
$3.56
WW:
4.92
NVO:
1.00
WW:
0.05
NVO:
0.95
WW:
0.00
NVO:
13.79
WW:
$765.94M
NVO:
$303.14B
WW:
$528.08M
NVO:
$255.65B
WW:
$60.81M
NVO:
$113.24B
Returns By Period
In the year-to-date period, WW achieves a -70.87% return, which is significantly lower than NVO's -22.31% return. Over the past 10 years, WW has underperformed NVO with an annualized return of -25.77%, while NVO has yielded a comparatively higher 11.19% annualized return.
WW
-70.87%
94.74%
-56.98%
-81.41%
-56.73%
-25.77%
NVO
-22.31%
7.45%
-37.66%
-47.77%
17.48%
11.19%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WW vs. NVO — Risk-Adjusted Performance Rank
WW
NVO
WW vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for WW International, Inc. (WW) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WW vs. NVO - Dividend Comparison
WW has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.45%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
WW WW International, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.45% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
WW vs. NVO - Drawdown Comparison
The maximum WW drawdown since its inception was -99.87%, which is greater than NVO's maximum drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for WW and NVO. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WW vs. NVO - Volatility Comparison
WW International, Inc. (WW) has a higher volatility of 138.18% compared to Novo Nordisk A/S (NVO) at 16.43%. This indicates that WW's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WW vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between WW International, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WW vs. NVO - Profitability Comparison
WW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, WW International, Inc. reported a gross profit of 132.88M and revenue of 186.57M. Therefore, the gross margin over that period was 71.2%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a gross profit of 65.20B and revenue of 78.09B. Therefore, the gross margin over that period was 83.5%.
WW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, WW International, Inc. reported an operating income of 7.35M and revenue of 186.57M, resulting in an operating margin of 3.9%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported an operating income of 38.79B and revenue of 78.09B, resulting in an operating margin of 49.7%.
WW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, WW International, Inc. reported a net income of -72.59M and revenue of 186.57M, resulting in a net margin of -38.9%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a net income of 29.03B and revenue of 78.09B, resulting in a net margin of 37.2%.